Targeted indoleamine-2,3-dioxygenase 1 nitrogen mustard inhibitor as well as preparation method and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- EAST CHINA UNIV OF SCI & TECH
- Publication Date
- 2018-05-04
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of medicine, in particular to a nitrogen mustard inhibitor targeting indoleamine-2,3-dioxygenase 1 and its preparation method and application. Background technique
[0002] Nitrogen mustards are still an important class of antineoplastic drugs in clinical application, such as Chlorambucil and Melphalan.
[0003]
[0004] The mechanism of action of this type of antitumor drug is that it can form electron-deficient ethyleneimine ions in the body, and then co-exist with electron-rich groups in biomacromolecules (such as DNA, RNA, or some important enzymes). Valence binding, inactivation or DNA molecule breakage, so as to achieve anti-tumor effect. Nitrogen mustard drugs have the advantages of broad anti-tumor spectrum and strong lethality to tumor cells, but they also have disadvantages such as low therapeutic efficiency, poor selectivity, and large toxic and side effects.
[0005] Indoleamine 2,3-dioxygen...